Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | GSR | P00390 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | SRC | P12931 | 1/20 | 0.36 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.36 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methyl Alcohol SCHEMBL9278113 | 0.97 | NPSR1 (0.41) | NPSR1CYP2D6CYP1A2PKMSMN1; SMN2 | |
| SCHEMBL4444556 | 0.87 | NPSR1 (0.39) | NPSR1CYP2D6CYP1A2PKMSMN1; SMN2 | |
| SCHEMBL286963 | 0.85 | GSR (0.43) | CYP2D6GSRMAPTALDH1A1SRC | |
| SCHEMBL22323630 | 0.85 | GSR (0.43) | CYP2D6GSRCYP2C19ALDH1A1SRC | |
| SCHEMBL5932816 | 0.84 | GSR (0.42) | CYP2D6GSRMAPTALDH1A1SRC | |
| SCHEMBL28844118 | 0.83 | KMT2A (0.42) | NPSR1SMN1; SMN2MAPTHTTCYP2C19 | |
| SCHEMBL16403466 | 0.83 | NPSR1 (0.41) | NPSR1CYP2D6CYP1A2PKMSMN1; SMN2 | |
| SCHEMBL5932183 | 0.82 | GSR (0.41) | CYP2D6GSRALDH1A1SRCLMNA | |
| SCHEMBL258789 | 0.82 | GSR (0.41) | CYP2D6SMN1; SMN2GSRALDH1A1SRC | |
| SCHEMBL3299147 | 0.82 | ALDH1A1 (0.49) | CYP2D6GSRALDH1A1SRC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 866 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117741125-A | Bioconjugates having light-generated acidic or basic releasable detection moieties on biological tissues | 美天施生物科技有限两合公司 | 2024-03-22 | — | — | CN | claimed |
| US-20200201178-A1 | PHOTOCURABLE COMPOSITION HAVING LOW SHRINKAGE AFTER CURING | CANON KABUSHIKI KAISHA (JP) | 2020-06-25 | — | — | US | claimed |
| WO-2017048710-A1 | LIGHT-CURABLE ARTICLE OF MANUFACTURE WITH PORTIONS OF DIFFERING SOLUBILITY | CARBON, INC. (US) | 2017-03-23 | — | — | WO | claimed |
| EP-2834313-A1 | CROSSLINKABLE COMPOSITION COMPRISING PHOTOBASE GENERATORS | 3M Innovative Properties Company (US) | 2015-02-11 | — | — | EP | claimed |
| WO-2013151739-A1 | CROSSLINKABLE COMPOSITION COMPRISING PHOTOBASE GENERATORS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2013-10-10 | — | — | WO | claimed |
| EP-2640780-A1 | UV CURABLE ANHYDRIDE-MODIFIED POLY(ISOBUTYLENE) | 3M Innovative Properties Company (US) | 2013-09-25 | — | — | EP | claimed |
| WO-2012067741-A1 | UV CURABLE ANHYDRIDE-MODIFIED POLY(ISOBUTYLENE) | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2012-05-24 | — | — | WO | claimed |
| WO-2012005806-A2 | SIGNAL-RESPONSIVE PLASTICS | THE PENN STATE RESEARCH FOUNDATION (US) | 2012-01-12 | — | — | WO | claimed |
| US-20090231979-A1 | OPTICAL RECORDING MEDIUM | KABUSHIKI KAISHA TOSHIBA | 2009-09-17 | — | — | US | claimed |
| WO-2003004141-A2 | KINASE MIMIC CATALYSTS FOR ASYMMETRIC SYNTHESIS OF PHOSPHORYLATED INSITOLS AND CYCLOALKANOLS | THE TRUSTEES OF BOSTON COLLEGE (US) | 2003-01-16 | — | — | WO | claimed |
| JP-9263635-A | — | — | None | — | — | JP | disclosed |
| US-20260079397-A1 | PHOTOSENSITIVE COMPOSITION, CURED PRODUCT, ELECTRONIC COMPONENT, AND METHOD FOR PRODUCING CURED PRODUCT | TORAY INDUSTRIES, INC. (JP) | 2026-03-19 | — | — | US | disclosed |
| EP-4692939-A1 | METHOD FOR USING DEGRADABLE FILM AND METHOD FOR PRODUCING RESIST PATTERN | LINTEC CORPORATION (JP) | 2026-02-11 | — | — | EP | disclosed |
| US-12497645-B2 | Self-immolative probes for enzyme activity detection | ENZO LIFE SCIENCES, INC. (US) | 2025-12-16 | — | — | US | disclosed |
| US-12473458-B2 | Sealing method | NITTO DENKO CORPORATION (JP) | 2025-11-18 | — | — | US | disclosed |
| EP-0730570-A1 | METHOD FOR MAKING INTERMEDIATES USEFUL IN SYNTHESIS OF RETROVIRAL PROTEASE INHIBITORS | G.D. SEARLE & CO. (US) | 1996-09-11 | — | — | EP | disclosed |
| WO-1996022275-A1 | METHOD OF PREPARING RETROVIRAL PROTEASE INHIBITOR INTERMEDIATES | G.D. SEARLE & CO. (US) | 1996-07-25 | — | — | WO | disclosed |
| US-5382637-A | Solid state chain extension polymerization between Lewis acid oligomers and deblocked Lewis bases | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 1995-01-17 | — | — | US | disclosed |
| EP-0119895-B1 | 1,2-DITHIOL-3-ONE DERIVATIVES, THEIR PREPARATION AND MEDICINAL COMPOSITIONS CONTAINING THEM | RHONE-POULENC SANTE (FR) | 1987-01-28 | — | — | EP | disclosed |
| EP-0119895-A1 | 1,2-Dithiol-3-one derivatives, their preparation and medicinal compositions containing them | RHONE-POULENC SANTE (FR) | 1984-09-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260079397-A1 | PHOTOSENSITIVE COMPOSITION, CURED PRODUCT, ELECTRONIC COMPONENT, AND METHOD FOR PRODUCING CURED PRODUCT | PPA1, PHOSPHO1, PHPT1 | NPSR1 3447/4885CYP2D6 4093/4885CYP1A2 3556/4885 |
| US-12497645-B2 | Self-immolative probes for enzyme activity detection | SORD, SI, IMMT | NPSR1 1771/4885CYP2D6 1126/4885CYP1A2 1002/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.